Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2002

View Archived Issues

Oncopharm patents antitumor cephalotaxines

Esteve presents novel anesthetics, sedatives, etc.

Novel HIV RT inhibitors identified at Parker Hughes Institute

beta3-Adrenoceptor agonists and their use in obesity, diabetes, etc.

New GSK-3 inhibitors in early development at Novo Nordisk

Multidrug resistance modulators identified at Procter & Gamble

Novel erythromycin A analogues in the pipeline at Ortho-McNeil

XTL-002 enters phase Ib trial in HCV

Corus enters licensing deal with BattellePharma for asthma drug delivery technology

Lilly and Teijin to jointly develop and commercialize Xigris in Japan

KW-2871 enters malignant melanoma study

Tularik and Sankyo collaborate on GPCR drug discovery

Multiple doses of NV-1020 feasible; efficacy demonstrated in pancreatic cancer peritoneal metastasis

Potent anticonvulsant activity reported for nonpeptide galanin receptor agonist

Guggulsterone effectively reduces cholesterol via antagonism of FXR receptor

Crystal structure of MECDP-synthase described by University of Dundee group

Targeted Genetics' arthritis program discussed at ASGT meeting, heads for clinical trials

INGN-241: new data presented at the Boston gene therapy meeting

Medarex and IDM partner to develop Cell Drugs in combination with MDX-010

Byk files for approval of ciclesonide for asthma in Canada

AC-3056 shows promise in atherosclerosis

Miravant and Bausch & Lomb to review SnET2 data with license option

Pharmexa updates AutoVac HER-2 DNA pharmaccine trial progress

Vasogen plans pivotal trial of immune modulation therapy

Sheffield completes phase I studies of NanoCrystal Budesonide product

MLN-341 (Velcade) enters pivotal phase III in multiple myeloma

I2S gives positive results in phase I/II Hunter's syndrome study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...